Direxion Daily Semiconductor Bull 3x Shares ETF
SOXL
VanEck Semiconductor ETF
SMH
Direxion Daily Financial Bull 3X Shares ETF
FAS
4
iShares US Home Construction ETF
ITB
5
SPDR S&P Homebuilders ETF
XHB
CA Stock MarketDetailed Quotes
Hemostemix Inc (HEM)
- 0.055
- 0.0000.00%
15min DelayTrading Jun 12 16:00 ET
10.88MMarket Cap-2.75P/E (TTM)
0.000High0.000Low689Volume0.000Open0.055Prev Close41.34Turnover0.16052wk High0.00%Turnover Ratio197.80MShares0.04052wk Low-0.02EPS TTM8.62MFloat Cap25.000Historical HighLossP/E (Static)156.79MShs Float0.035Historical Low-0.029EPS LYR0.00%Range %--Dividend TTM-1.96P/B1Lot Size--Div Yield TTM
HEM Stock Chart
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
HEM Orderflow
Unit: --
HEM Orderflow Trend
IntradayDayWeekMonth
No Data
Hemostemix Inc (HEM) News
Hemostemix Inc: MDA EN
Hemostemix Inc: AUDITED ANNUAL FINANCIAL STATEMENTS EN
Hemostemix Raises $784,000 to Advance Stem Cell Therapy Commercialization
Hemostemix Leadership Attending Abundance360 Summit
Hemostemix Appoints Renowned Vascular Surgeon and Principal Investigator, Dr. York Hsiang, as Business Consultant to Advance First Nations-Led Healthcare Partnerships
Hemostemix Raises C$480,000 to Advance Stem Cell Therapy Commercialization
Hemostemix Inc (HEM) Stock Forum
$Firefly Neuroscience (AIFF.US)$ $Hemostemix Inc (HEM.CA)$
Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
Hemostemix (TSXV: HEM) and Firefly Neuroscience (NASDAQ: AIFF) have announced a collaboration to conduct a Phase 1 clinical trial studying ACP-01 as a treatment for vascular dementia. The trial will evaluate brain wave activity in up to 100 patients using Firefly's FDA-Cleared BNA™ platform.
The ...
Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
Hemostemix (TSXV: HEM) and Firefly Neuroscience (NASDAQ: AIFF) have announced a collaboration to conduct a Phase 1 clinical trial studying ACP-01 as a treatment for vascular dementia. The trial will evaluate brain wave activity in up to 100 patients using Firefly's FDA-Cleared BNA™ platform.
The ...
5
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)